Smith Thornton Advisors’s Merck MRK Stock Holding History

Smith Thornton Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$609K	Buy	4,908 +473	+11%	+$55.4K	0.27%	74
2026 Q1	$534K	Hold	4,435	–	–	0.27%	79
2025 Q4	$467K	Buy	4,435 +56	+1%	+$5.26K	0.24%	86
2025 Q3	$368K	Buy	4,379 +42	+1%	+$3.46K	0.19%	99
2025 Q2	$343K	Sell	4,337 -30	-0.7%	-$2.38K	0.2%	105
2025 Q1	$392K	Sell	4,367 -731	-14%	-$68.3K	0.24%	87
2024 Q4	$507K	Buy	5,098 +566	+12%	+$58.4K	0.32%	78
2024 Q3	$515K	Buy	4,532 +130	+3%	+$15.4K	0.34%	78
2024 Q2	$545K	Buy	+4,402	New	+$567K	0.4%	69

Other funds holding MRK

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return

Smith Thornton Advisors's MRK Position: Q2 2026 in Review

Smith Thornton Advisors increased its Merck (MRK) stake by 11% in Q2 2026, buying an estimated $55.4K and bringing the position to 4,908 shares worth $609K. The position accounts for 0.27% of the portfolio, ranked #74.

Smith Thornton Advisors first reported a position in MRK in Q2 2024 and has held it in 9 quarters since. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Smith Thornton Advisors held 4,908 shares of Merck worth $609K as of Q2 2026.
Smith Thornton Advisors bought 473 Merck shares in Q2 2026, an estimated $55.4K.
Merck made up 0.27% of Smith Thornton Advisors's portfolio in Q2 2026, its #74 holding.
Smith Thornton Advisors first reported a position in Merck in Q2 2024 and has held it in 9 quarters since.
1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Smith Thornton Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.